Table 3.
Ongoing treatments of RA patients.
| Variable | Value |
|---|---|
| Hydroxycloroquine, n (%) | 7 (11) |
| Methotrexate, n (%) | 35 (56) |
| Leflunomide, n (%) | 6 (10) |
| Sulfasalazine, n (%) | 1 (2) |
| Biologic therapies, n (%) | 28 (45) |
| Glucocorticoids, n (%) | 15 (24) |
| NSAIDs, n (%) | 4 (6) |
| ACE inhibitors, n (%) | 36 (58) |
| Angiotensin II receptor blockers, n (%) | 3 (5) |
| Calcium-antagonists, n (%) | 6 (10) |
| Diuretics, n (%) | 5 (8) |
| Beta-blockers, n (%) | 7 (11) |
| Statins, n (%) | 3 (5) |
| Insulin, n (%) | 4 (6) |
| Other hypoglycaemic drugs, n (%) | 1 (2) |
ACE: angiotensin converting enzyme; NSAIDs: non-steroidal anti-inflammatory drugs; RA: rheumatoid arthritis.